At the experimental endpoint, tumors were harvested (Fig. 7B), and tumor weight of control group was remarkably higher than that of GXYLT2 knockdown group (sh2; p < 0.01; Fig. 7C). The gene discussed is GXYLT2; the disease is neoplasm.